Announcements Trials
Browse Landscape

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Pancreatic Neoplasms 35Pancreatic Fistula 4Pancreatic Ductal Adenocarcinoma 2Jaundice, Obstructive 2Gastroparesis 2Bile Duct Neoplasms 2Recurrence 1Peritoneal Diseases 1Periampullary Cancer 1Pancreatitis, Chronic 1Pancreatic Adenocarcinoma 1Obesity 1Non-alcoholic Fatty Liver Disease 1Neoplasm Metastasis 1Metabolic Syndrome 1Locally Advanced Pancreatic Adenocarcinoma 1Hypoxia 1Hemorrhage 1Gastrointestinal Stromal Tumor of Duodenum 1Fatty Liver 1Diabetes Mellitus 1Cholangiocarcinoma 1Carcinoma, Pancreatic Ductal 1Adenocarcinoma 1

Interventions

Cyclophosphamide 155Dexamethasone 141Rituximab 85fludarabine 80Lenalidomide 72Cytarabine 70Bortezomib 65fludarabine phosphate 63Gemcitabine 62venetoclax 55pomalidomide 53Etoposide 53pembrolizumab 52Paclitaxel 48Cisplatin 48Carboplatin 48Peripheral Blood Stem Cell Transplantation 47Filgrastim 40Radiotherapy 39Busulfan 37Calcium Dobesilate 36Methotrexate 34Melphalan 34Bevacizumab 33carfilzomib 32Cyclosporine 32Azacitidine 32Mycophenolic Acid 30Vincristine 29Bendamustine Hydrochloride 29

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recurrence × Pancreaticoduodenectomy × Clear all
NCT04596865 2023-11-18

Recurrence After Whipple's (RAW) Study

University Hospital Plymouth NHS Trust

Completed
1,484 enrolled
Gastrointestinal

Bile Duct Neoplasms, Pancreatic Neoplasms, Recurrence, Cholangiocarcinoma, Carcinoma, Pancreatic Ductal

Data powered by HemOnc (CC BY 4.0) Colophon âš¡